Insilico Medicine
Insilico Medicine is a globally leading clinical-stage end-to-end generative artificial intelligence (AI)-driven biotechnology company founded in 2014 at the Emerging Technology Centers of Johns Hopkins University in Baltimore, Maryland, USA.
